Introduction {#Sec1}
============

Eukaryotic cells contain membrane-enclosed compartments with specialized functions; these compartments are connected by membrane traffic via transport vesicles. Communication between cells is mediated by receptors on the plasma membrane and by the secretion of soluble signaling molecules. These proteins are transported to the cell surface via the endoplasmic reticulum, Golgi, and trans Golgi network. Signal transduction can be regulated by the endocytosis of cell surface receptors. These receptors can either be targeted from early endosomes via late endosomes to lysosomes for degradation (Perret et al. [@CR22]) or recycled back to the cell surface for further signaling. In addition, endosomes can play an active role in certain signaling pathways because they contain specific signal transducers (Polo and Di Fiore [@CR23]).

Complex protein machinery is required for recognition between transport vesicle and target membrane and the subsequent fusion of these membranes. SNAREs (soluble-*N*-ethylmaleimide-sensitive factor attachment protein receptor) play a key role in these processes (Jahn and Scheller [@CR18]). The SNAREs found on transport vesicles and target membranes form complexes via their conserved SNARE motifs bridging the gap between both membranes and initiating membrane fusion. These SNARE complexes have a conserved structure consisting of four SNARE motifs forming an extended parallel bundle of four α-helices (Sutton et al. [@CR32]). Whereas most SNAREs contain a single SNARE motif, a few SNARE proteins such as SNAP23 and SNAP29 contribute two SNARE motifs to SNARE complexes. Specific SNARE complexes have been assigned to specific transport steps. Homotypic fusion of late endosomes is mediated by a SNARE complex composed of VAMP8 (also called endobrevin), vti1b, syntaxin 7, and syntaxin 8 in vitro (Antonin et al. [@CR2]). Transport from late endosomes to lysosomes requires vti1b, syntaxin 7, syntaxin 8, and VAMP7. VAMP7 replaces VAMP8 in this transport step (Pryor et al. [@CR24]). *Vamp8*^−/−^ mice are reported to have defects in regulated exocytosis of exocrine zymogen granules and other exocrine secretory granules (Wang et al. [@CR35], [@CR36]). These data demonstrate that VAMP8 is required for exocytosis in the exocrine system in a complex with syntaxin 4 and SNAP23. VAMP8 is also involved in regulated exocytosis of dense granules, alpha granules, and lysosomes from platelets (Ren et al. [@CR25]) and in secretion from mast cells (Lippert et al. [@CR20]). Here, we have set out to extend studies of mice deficient for VAMP8. A particularly obvious phenotype is that these mice have an extremely small thymus. Therefore, we have concentrated our analysis of the effects of VAMP8 deficiency on thymus morphology and T lymphocyte development.

The thymus is responsible for the generation of T lymphocytes that respond to foreign antigens but not to self-antigens (Starr et al. [@CR29]; Hogquist et al. [@CR15]). Precursor cells from the bone marrow enter the thymus and undergo multiple and tightly regulated developmental steps, which include the rearrangement and expression of T cell receptor (TCR) genes, the positive selection of cells that can interact with self-major histocompatibility complex (MHC) molecules, and the negative selection of cells that strongly recognize self-antigens. The developing cells undergo phases of intense proliferation; however, about 98% of the thymocytes that develop in the thymus die by apoptosis because they do not meet the selection criteria (Egerton et al. [@CR8]; Strasser and Bouillet [@CR31]). The development of thymocytes depends on the interaction with stromal cells, which include epithelial cells, dendritic cells, macrophages, and fibroblasts. The thymocytes migrate during their development through multiple microenvironments in the cortex and medulla of the thymus (Takahama [@CR33]). Each step in development is characterized by the expression of a specific set of cell surface molecules that can be used to analyze the T lymphocyte maturation. The most prominent stages are distinguished on the basis of CD4 and CD8 co-receptor expression. Immature CD4^−^CD8^−^ double-negative (DN) thymocytes transiently become CD4^+^CD8^+^ double-positive (DP) thymocytes before CD4^+^ or CD8^+^ single-positive (SP) T lymphocytes are generated that subsequently leave the thymus and enter the circulation. Multiple signaling events are involved in the maturation of T lymphocytes in which the amplitude and duration of signaling is often the key factor for the outcome, i.e., proliferation and progress in maturation or cell death by apoptosis. These signaling pathways are controlled by intracellular enzymes, regulatory proteins, adaptor molecules, transcription factors, and cell surface receptors. The subcellular organization of these signaling pathways could also depend on the function of the SNARE protein machinery.

We show herein that the cytoarchitecture of the thymus and subsequently the T lymphocyte development is severely disturbed in a subset of VAMP8-deficient mice. The apoptosis of thymocytes increases, and their proliferation decreases. This is the first description of a SNARE protein deficiency leading to severe alterations of the organization of thymic epithelial cells (TEC) and T cell development.

Materials and methods {#Sec2}
=====================

Mice and genotyping {#Sec3}
-------------------

*Vamp8*^tm1Lex^ (OST20346; Zambrowicz et al. [@CR37]) were maintained on a mixed genetic background of 129SvJ and C57BL/6 strains. Heterozygous animals were used for breeding. All animal experiments were approved by the local government and were in accordance with institutional guidelines for the welfare of animals. Heterozygous littermates were always used as controls for the knockout mice. Between day 5 and day 16 after birth, the weight and health status of the *Vamp8*^−/−^ mice were recorded daily to document the phenotype of individual mice. DNA was obtained for genotyping from tail biopsies. Primers specific for the *Vamp8* wild-type allele (5′-CCGAAACAAGACAGAGGACTTG-3′ and 5′-CGTTAGGAATGGAGCAGTTGAC-3′) and for the puro^r^ cassette of the mutant allele (5′-CCGAGTACAAGCCCACGGTG-3′ and 5′-CGCTGCCCAGACCCTTGCCC-3′) were used for polymerase chain reaction (PCR) amplification and gave products of 290 bp and 400 bp, respectively.

Western blot analysis {#Sec4}
---------------------

Freshly excised tissues were homogenized in TRIS-buffered saline (150 mM NaCl, 50 mM TRIS-HCl pH 7.4) in an Ultra-Turrax homogenizer. The homogenates were supplemented with 0.1% Triton X-100 and protease inhibitors (1 mM phenylmethylsulfonylfluoride, 0.5 μg/ml leupeptin, 1.0 μg/ml pepstatin). Total protein (30 µg) was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes (PROTRAN, Schleicher and Schuell, Germany). Polyclonal antibodies directed against vti1a, vti1b (Antonin et al. [@CR3]), SNAP29, syntaxin 7, syntaxin 8 (Antonin et al. [@CR2]; Kreykenbohm et al. [@CR19]), and VAMP8 (Synaptic Systems, Göttingen, Germany) were used for detection, and the bands were visualized by enhanced chemiluminescence (Pierce, Rockford, USA). For the detection of VAMP8, 1 mg Triton-X-100-free homogenate was subjected to Triton X-114 extraction to enrich membrane proteins (Bordier [@CR5]). The detergent fraction was concentrated by acetone precipitation.

Histology {#Sec5}
---------

Tissue samples were fixed in 4% formaldehyde and embedded in paraffin. Thick sections (5--10 µM) were obtained, deparaffinized, and stained with hematoxylin and eosin (HE). TUNEL (terminal deoxnucleotidyl transferase dUTP nick end labeling) staining to visualize the DNA breaks in apoptotic cells was performed with deparaffinized sections according to manufacturer's instructions (Dead EndTM Fluorometric TUNEL System; Promega Corporation, Madison, Wis., USA; Fayyazi et al. [@CR11]). For immunohistology, deparaffinized sections were renaturated by microwaving for 20 min in 0.1 M citrate buffer (pH 6) and incubated with rabbit anti-keratin 5 (Covance Research, Richmond, Calif., USA; 1:1000) and anti-keratin 8 (TROMA-1, Developmental Studies Hybridoma Bank, Iowa City, Iowa, USA; 1:30) antibodies overnight at 4°C. Primary antibodies were detected with anti-rat Alexa 488 (Invitrogen, 1:300) and anti-rabbit Cy3 (Jackson Immunoresearch Laboratories, West Grove, Pa., USA; 1:200) secondary antibodies. Sections were examined by using a Leica DM5000.

Single cell preparations {#Sec6}
------------------------

Thymi of the mice were dissected, and adjacent lymph nodes were carefully removed when necessary. Single cell suspensions were prepared in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, and antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin) by using a Tenbroek homogenizer, and cell numbers were determined in a Neubauer counting chamber. Single cell suspensions from other lymphoid organs were obtained similarly. Erythrocytes were removed from blood samples and spleen cell preparations by incubation for 5 min in erythrocyte lysis buffer (155 mM NH~4~Cl, 10 mM KHCO~3~, 0.1 mM EDTA, pH 7.4--7.8).

Flow cytometry {#Sec7}
--------------

Usually, 1×10^6^ cells per measurement were washed in 5-ml polystyrene tubes with phosphate-buffered saline (PBS) and resuspended in 100 µl PBS before cell surface staining with 1 µg of the respective antibodies: anti-CD3 (clone CT-CD3, rat IgG2a, phycoerythrin \[PE\]-labeled; Caltag Laboratories, Hamburg, Germany), anti-CD4 (clone CT-CD4, rat IgG2a, PE or tricolor \[TC\]-labeled; Caltag), anti-CD8a (clone CT-CD8a, rat IgG2a, fluorescein isothiocyanate \[FITC\] or PE-labeled), anti-CD8b (clone CT-CD8b, rat IgG2a, PE-labeled; Caltag), anti-CD19 (clone 6D5, rat IgG2a, FITC-labeled; Caltag), anti-CD25 (clone 7D4, rat IgM, FITC-labeled, Becton Dickinson), anti-CD44 (clone IM7.8.1, rat IgG2b, biotin-labeled; Caltag), anti-CD45R/B220 (clone RA3-6B2, rat IgG2a, PE-labeled; Caltag), anti-mouse NK cells (clone DX5, rat IgM, PE-labeled; Caltag), anti-mouse NK1.1 (clone PK136, mouse IgG2a, PE-labeled; Caltag), anti-Ly-6G (clone RB6-8C5, rat IgG2b, PE-labeled; Caltag), anti-mouse erythroid cells (clone TER-119, rat IgG2b, PE-labeled; Caltag), anti-TCRαβ (clone H57-597, hamster IgG, FITC-labeled; Caltag), or anti-I-A^b^ (clone 25-5-16S, mouse IgM, FITC-conjugated). TC-conjugated streptavidin (SA1006, Caltag) was used as the secondary reagent. Appropriate isotype controls were purchased from Caltag Laboratories. The cells were stained for 45 min at 4°C before being washed and resuspended in 200 µl PBS. Exposure of phosphatidylserine as a membrane parameter of apoptosis was determined by staining cells for 45 min at 4°C in binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl~2~) with 5 µl annexin V-FITC (Becton Dickinson) in combination with 1 µg/ml propidium iodide (Sigma) to distinguish early apoptotic from late apoptotic or necrotic cells. The cells were resuspended in 200 µl annexin binding buffer before measurement. DNA histograms were obtained after propidium iodide staining of cells fixed in ethanol as described previously (Ormerod et al. [@CR21]; Dressel et al. [@CR7]). Flow cytometry was performed on a FACScan flow cytometer with CellQuest software (Becton Dickinson, Heidelberg, Germany); 10,000 to 50,000 cells per sample were counted. Lymphocytes were gated on the basis of their forward scatter/side scatter characteristics.

Dexamethasone and FAS-induced apoptosis {#Sec8}
---------------------------------------

Thymocytes (1×10^6^) were transferred to two 5-ml polystyrene tubes for each time point. Cells in the first tube were resuspended in 200 µl 0.1 µM dexamethasone (Sigma Taufkirchen, Germany) diluted in RPMI-1640 medium. In the second control tube, 200 µl RPMI-1640 supplemented medium was added. The cells were incubated at 37°C for 0, 3, and 6 h. For induction of apoptosis with an agonistic anti-FAS antibody (clone Jo2, Becton Dickinson), 2×10^6^ cells were resuspended in 200 µl supplemented RPMI-1640 medium and exposed to 1 µg of the antibody for 0, 3, and 6 h at 37°C. The cells in the control tubes were incubated with 200 µl of the supplemented medium only. After each time point, the cells were washed once with binding buffer and stained with annexin V-FITC and propidium iodide. The cells were finally resuspended in 200 µl of the binding buffer before flow cytometry was performed. The number of viable cells was compared in the treated and untreated samples for each time point. In parallel, cells were fixed in ice-cold ethanol in order to determine apoptotic cells by subG1 peak analysis in DNA histograms.

Anti-CD3 and anti-CD28 antibody-mediated apoptosis {#Sec9}
--------------------------------------------------

The assay was carried out as described elsewhere (Thien et al. [@CR34]) in 96-well ELISA plates (F96 Maxisorp, Nunc, Roskilde, Denmark) that had been coated with 10 µg/ml anti-CD3 (clone 2C11, Becton Dickinson) and anti-CD28 (clone 37.51, Becton Dickinson) antibody mix, overnight at 4°C. Thymocytes (2×10^6^) were transferred to each of the wells and incubated for 0, 3, 6, and 24 h. For each time point, a control sample was incubated in an uncoated well with 100 µl medium. The cells were collected in 5-ml polystyrene tubes and washed with annexin V binding buffer before being stained with annexin V-FITC and propidium iodide.

Reconstitution assays {#Sec10}
---------------------

Bone marrow cell suspensions were isolated from small and sick *Vamp8*^−/−^ mice and healthy heterozygous littermates. The bone marrow cells (1×10^6^) were intravenously injected into irradiated (9 Gy) *Rag2*^−/−^*γc*^−/−^ mice; these mice are deficient for T and B lymphocytes and natural killer (NK) cells because of a knockout of the recombination activation gene 2 and the common γ chain gene, which encodes a protein that is part of several cytokine receptors (Cao et al. [@CR6]). At various time points after transplantation, peripheral blood was collected and analyzed by flow cytometry for reconstitution with B and T lymphocytes. From later sacrificed animals, thymi and spleens were also obtained and analyzed by flow cytometry.

Statistics {#Sec11}
----------

Differences between multiple experimental groups were analyzed by using the nonparametric Kruskal-Wallis test and WinSTAT software. Paired comparisons between two groups were performed by using the nonparametric Mann-Whitney U test. A significance level of *P* = 0.05 was used. Adjustments for multiple comparisons were performed when appropriate with the Bonferroni-Holm procedure.

Results {#Sec12}
=======

VAMP8-deficient mice were obtained by a gene trap strategy {#Sec13}
----------------------------------------------------------

Lexicon Genetics (The Woodlands, USA) created a library of mutant mouse embryonic stem cells by using a gene trap strategy involving random insertional mutagenesis (Zambrowicz et al. [@CR37]). The employed gene trap vector VICTR20 consisted of a splice acceptor site, followed by an internal ribosome entry site, a galactosidase/neomycin phosphotransferase fusion gene, and a polyadenylation signal yielding a first mRNA. The second part of VICTR20 contained a phosphoglycerate kinase-1 promoter, a puromycin N-acetyltransferase gene, and a splice acceptor sequence generating a second mRNA, which was used to determine the point of insertion. Mice were generated from OST20346 by the Merck Genome Research Institute, and we obtained them from Jackson Laboratory (Bar Harbor, USA) as strain *Vamp8*^tm1Lex^.

The *Vamp8* gene encompasses four exons. Exon 1 encodes the 5′ untranslated region (UTR), exon 2 encodes the 5′ UTR and the first amino acid M1, exon 3 (nucleotides 2637--2796 in the mouse genomic DNA clone with GenBank accession number AF247556) encodes amino acids (aa) E2-T54, and exon 4 (nucleotides 5452--5727) encodes aa S55-T101 and the 3′ UTR. The SNARE motif of VAMP8 is encoded in part by exon 3 (aa 13--54) and exon 4 (aa 55--62).

In order to localize the insertion cassette to a definite position, we performed several sets of PCRs with different forward and reverse primers. We pinpointed the site of the gene trap insertion in intron 3 following exon 3 between nucleotides +10 and +253 (data not shown). *Vamp8* mRNA was not detected by Northern blot in homozygote-null heart and muscle and was barely detected in kidney (Jackson Laboratory), despite the kidney being reported to have the highest levels of *Vamp8* mRNA (Advani et al. [@CR1]). Both mRNAs encoded by the gene trap allele cannot encode functional proteins, because both mRNAs encode only part of the SNARE motif, which is essential for function.

SNARE expression profiling of VAMP8-deficient mice confirmed the loss of VAMP8 protein in the thymus {#Sec14}
----------------------------------------------------------------------------------------------------

In order to confirm that the *Vamp8*^tm1Lex^ mice did not contain significant amounts of VAMP8 protein, we determined the protein levels in *Vamp8*^+/+^, *Vamp8*^+/−^, and *Vamp8*^−/−^ mice by Western blot. We focused on thymus because this organ was abnormal in *Vamp8*^−/−^ mice (see below). VAMP8 was present in the thymus of *Vamp8*^+/+^ and *Vamp8*^+/−^ mice but not in *Vamp8*^−/−^ mice (Fig. [1](#Fig1){ref-type="fig"}). Thus, loss of VAMP8 could have functional consequences for the function of the thymus and the development of T lymphocytes. Our previous work indicated that syntaxin 8 is degraded in the absence of vti1b in *Vti1b*^−/−^ mice (Atlashkin et al. [@CR4]). Therefore, we wanted to know whether the expression levels of other SNARE proteins were changed because of the absence of VAMP8. Lack of VAMP8 did not significantly alter the amount of the VAMP8 complex partners syntaxin 8 or vti1b (Fig. [1](#Fig1){ref-type="fig"}). We also did not observe major changes in the amounts of syntaxin 7, the fourth member of the late endosomal SNARE complex (data not shown). The loss of the late endosomal SNARE complex could be compensated by other SNAREs. However, major changes in the amounts of SNAP29 or of the early endosomal SNARE vti1a were not observed (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1SNARE protein VAMP8 was not expressed in the thymus of *Vamp8*^−/−^ mice. A SNARE protein expression profile was determined in thymi from 1.5-month-old *Vamp8*^+/+^, *Vamp8*^+/−^, and *Vamp8*^−/−^ mice by immunoblot. For the detection of syntaxin 8, SNAP29, vti1a, and vti1b, 30 µg total protein derived from thymus homogenate was loaded in each lane. For the detection of VAMP8, 250 µg total protein was subjected to Triton X-114 extraction, and the precipitated membrane protein fraction was loaded onto the gel

Ablation of VAMP8 caused early mortality {#Sec15}
----------------------------------------

*Vamp8*^−/−^ mice were born in the expected Mendelian ratio indicating normal prenatal development. However, 20 out of 55 *Vamp8*^−/−^ mice died before reaching the age of 1 month. In comparison, only 2% (2 out of 88) of *Vti1b*^−/−^ mice (Atlashkin et al. [@CR4]) that we bred in parallel were lost during this time. Up to postnatal day 7, all *Vamp8*^−/−^ mice showed normal weight gain. After this time, 36% of the mice lost weight for 2--3 days and eventually died (Fig. [2](#Fig2){ref-type="fig"}a). One day after begin of weight loss, the mice were smaller than their heterozygous littermates, but they were active and apparently healthy. We described this stage as "small and healthy". After consecutive weight loss for 2--3 days, the mice appeared very weak, had a shivery gait, and on average weighed 1.8-fold less than their heterozygous littermates (Fig. [2](#Fig2){ref-type="fig"}b,c). This stage was described as "small and sick", and these mice eventually died. The weight-gain pattern of *Vamp8*^+/−^ mice was indistinguishable from wild-type mice. The *Vamp8*^−/−^ mice that survived these early postnatal days became healthy fertile adults but remained smaller and lighter than their heterozygous littermates. Fig. 2Growth pattern of *Vamp8*^−/−^ mice revealed a heterogeneous phenotype. **a** Weight-gain pattern of a representative litter illustrates heterogeneity in the phenotype of VAMP8-deficient mice. One *Vamp8*^−/−^ pup lost weight starting at postnatal day 9, became sick, and eventually died. The other *Vamp8*^−/−^ pup survived and gained weight as did the *Vamp8*^+/−^ pups. **b** A summary of the mean weights (±SD) of sick 8- to 12-day-old *Vamp8*^−/−^ mice that died and their heterozygous littermates is shown. The weight of *Vamp8*^−/−^ mice was, on average, 3.9±0.7 g compared with 7.6±1.4 g for *Vamp8*^+/−^ littermates (*n* = 7, *P* = 0.0016, U test). **c** Representative photograph of a small and sick *Vamp8*^−/−^ mouse and a heterozygous littermate illustrating the differences in size and weight of these animals. **d** The size of the thymus of the *Vamp8*^−/−^ mouse was disproportionally smaller than that of its herterozygous littermate (representative photograph)

VAMP8-deficient mice showed disrupted thymus morphology {#Sec16}
-------------------------------------------------------

Liver, kidney, heart, brain, intestine, spinal cord, and thymus from small and sick *Vamp8*^−/−^, healthy *Vamp8*^−/−^ (1 month old), and wild-type mice were examined histologically. All organs from the small and sick *Vamp8*^−/−^ mice were normal and similar to those of wild-type mice, except for the thymus and pancreas. Thymi from the small and sick *Vamp8*^−/−^ mice were much smaller than the thymi from the *Vamp8*^+/−^ littermates (Fig. [2](#Fig2){ref-type="fig"}d). The thymus size of *Vamp8*^+/−^ mice was similar to that of wild-type mice (data not shown). Thymus sections from a 10-day-old wild-type mouse showed a well-defined compartmentalization into cortex and medulla (Fig. [3](#Fig3){ref-type="fig"}a). The thymus of the healthy adult *Vamp8*^−/−^ mouse appeared similar to the wild-type thymus with distinct cortical and medullary regions (Fig. [3](#Fig3){ref-type="fig"}b). In contrast, thymi from small and sick *Vamp8*^−/−^ mice did not show a morphological distinction into medulla and cortex (Fig. [3](#Fig3){ref-type="fig"}c). The thymi of *Vamp8*^−/−^ and *Vamp8*^+/−^ mice at day 7 before animals started to loose weight were histologically similar (data not shown). To determine further the basis of the missing compartmentalization of the thymus in *Vamp8*^−/−^ mice, we analyzed the thymus epithelium in small and sick and in small and healthy *Vamp8*^−/−^ mice by immunofluorescence microscopy. Cortex and medulla contain different thymic epithelial cells (TEC), which are crucial components of the various thymic microenvironments and guide T cell development (Takahama [@CR33]). Medullary thymic epithelial cells (mTEC) were identified by the presence of keratin 5, and cortical thymic epithelial cells (cTEC) by keratin 8 expression (Franke et al. [@CR12]; Klug et al. [@CR17]). Both keratin-5-positive and keratin-8-positive cells were present in thymi from small and sick *Vamp8*^−/−^ mice (data not shown) and in small and healthy *Vamp8*^−/−^ mice (Fig. [4](#Fig4){ref-type="fig"}a--b''). However, the normally strict boundary between cTEC and mTEC was ill-defined, even in the small and healthy *Vamp8*^−/−^ mice, as compared with that of their *Vamp8*^+/−^ littermates (Fig. [4](#Fig4){ref-type="fig"}c--d'') and wild-type mice (Fig. [4](#Fig4){ref-type="fig"}e--f''). Both epithelial cell types were mixed and severely disordered. These data indicated that absence of VAMP8 resulted in a disorganization of thymus epithelium even in small and healthy *Vamp8*^−/−^ mice several days before the onset of the most dramatic phenotypes (see below). In addition, we observed a histological defect in the pancreas of all *Vamp8*^−/−^ mice (data not shown). These mice had an abnormally large and creamy pancreas as described previously for a different line of *Vamp8*^−/−^ mice (Wang et al. [@CR35]). Fig. 3VAMP8 deficiency leads to histopathological alterations of the thymus. Hematoxylin and eosin staining of sections from the thymus of a 10-day-old wild-type mouse (**a**) and a healthy adult *Vamp8*^−/−^ mouse (30 days old, **b**) showing two compartments: cortex (*Co*) and medulla (*Me*). The thymus of a small and sick *Vamp8*^−/−^ mouse (11 days old, **c**) did not show the characteristic compartmentalization into cortex and medulla. Medullary cells (*pink*) were scattered throughout the thymic cortex (*blue*). Micrographs taken at ×100 magnification, *bars* 100 µmFig. 4VAMP8 deficiency leads to altered distribution of cortical thymic epithelial cells (cTEC) and medullary thymic epithelial cells (mTEC). mTEC were identified by keratin 5 (*red*) and cTEC by keratin 8 (*green*) immunostaining. Both cell populations were present in a small and healthy *Vamp8*^−/−^ mouse (8 days old, **a--b''**). However, their distribution was scattered and disorganized in comparison with a *Vamp8*^+/−^ control littermate (**c--d''**) and a wild-type mouse (8 days old, **e--f''**). Fluorescence micrographs taken at a magnification of ×100, *bars* 50 µm (**a**, **c**, **e**); enlargements of *boxed areas* taken at ×400, *bars* 10 µm (**b**, **d**, **f**)

*Vamp8*^−/−^ mice showed a reduction in thymus cellularity and the thymocyte subsets were altered {#Sec17}
-------------------------------------------------------------------------------------------------

The numbers of thymocytes were significantly reduced in small *Vamp8*^−/−^ mice (Table [1](#Tab1){ref-type="table"}). The small and sick stage was the most severely affected and showed a 10-fold reduction in thymocyte counts compared with their heterozygous littermates. Interestingly, the total cell count in the thymi of small and healthy *Vamp8*^−/−^ mice was also reduced and about half of the *Vamp8*^+/−^ control littermates. In contrast, no significant reduction was seen in the thymus cell count in healthy *Vamp8*^−/−^ at day 7 before the deleterious phenotype occurred or in healthy adult mice (Table [1](#Tab1){ref-type="table"}). We wanted to know at which stage VAMP8 deficiency affected the development of thymocytes in the small and sick *Vamp8*^−/−^ mice. The switching from CD4^−^CD8^−^ DN precursors to CD4^+^CD8^+^ DP and eventually to mature CD4^+^ or CD8^+^ SP T lymphocytes defines major steps in the development of thymocytes. Therefore, we analyzed these markers on thymocytes from small and sick, small and healthy, healthy 7-day-old, and healthy adult *Vamp8*^−/−^ mice and on thymocytes of heterozygous littermates by flow cytometry (Fig. [5](#Fig5){ref-type="fig"}a). The percentage of CD4^+^CD8^+^ DP cells was significantly reduced (on average 1.6-fold) in small and sick *Vamp8*^−/−^ mice, whereas the percentage of CD4^+^ SP was significantly increased (on average 4.3-fold). The proportion of the other thymocyte populations showed a tendency to increase (CD8^+^ SP on average 3.2-fold and CD4^−^CD8^−^ DN on average 2.5-fold); however, this was not statistically significant after correction for multiple testing (Fig. [5](#Fig5){ref-type="fig"}b). Of note, although the proportion of DN and SP thymocytes appeared to increase in the thymi of small and sick *Vamp8*^−/−^ mice, the absolute number of all four cell populations significantly decreased (Fig. [5](#Fig5){ref-type="fig"}b). The *Vamp8*^−/−^ mice had only 9% of the DP cell numbers found in the heterozygous littermates. For the DN cells, this proportion was 20%, for CD8^+^ SP cells 25%, and for CD4^+^ SP cells 36%. There was no difference in the CD4/CD8 subsets in thymi of small and healthy *Vamp8*^−/−^ mice (Fig. [5](#Fig5){ref-type="fig"}c), in *Vamp8*^−/−^ mice at day 7 before a fraction of mice became sick (data not shown), or in adult *Vamp8*^−/−^ mice (data not shown) compared with the respective controls. Fig. 5Proportion of CD4^+^CD8^+^ DP thymocytes was decreased in small and sick *Vamp8*^−/−^ mice. **a** Representative flow cytometric analysis of thymocytes from a 10-day-old small and sick *Vamp8*^−/−^ mouse showing the presence of the four major subpopulations defined by CD4 and CD8 markers. The proportion of DP cells was drastically reduced compared with that of a heterozygous littermate. **b** Summary of the proportion of CD4/CD8 subsets obtained from small and sick *Vamp8*^−/−^ mice and heterozygous littermates (*bars* percentage of thymocytes subpopulations ±SD; *n* = 5, age: 9--12 days, \**P* \< 0.05, U test, corrected for multiple testing). The absolute cell number of CD4/CD8 subsets in 9- to 13-day-old small and sick *Vamp8*^−/−^ mice and heterozygous littermates is given *below* (*P* = 0.0039, U test, for the comparisons of *Vamp8*^--/--^ and *Vamp8*^+/--^ mice). **c** Small and healthy *Vamp8*^--/--^ mice did not show alterations of thymocytes subsets compared with heterozygous littermates (*n* = 3, age: 9--12 days). **d** Representative histogram of T cell receptor-αβ (TCRαβ) staining of thymocytes from a small and sick *Vamp8*^−/−^ mouse and a heterozygous littermate (*dotted line* cells stained with the isotype control, *solid line* staining with an anti-TCR antibody). As seen *left*, the percentage of cells expressing the TCR at high intensity was increased in the small and sick *Vamp8*^--/--^ mice compared with the heterozygous littermate (*right*). However, the intensity of fluorescence was in the same range for the TCR^high^ (marker *M2*: mean fluorescence intensity 232 for *Vamp8*^−/−^ and 258 for *Vamp8*^+/−^) and the TCR ^low^ (marker *M1*: mean fluorescence intensity 45 for *Vamp8*^−/−^ and 39 for *Vamp8*^+/−^) cells in the small and sick *Vamp8*^−/−^ mice and in the control miceTable 1Total thymocyte numbers in various groups of *Vamp8*^−/−^ mice compared with controlsGenotypePhenotypeAgeNumberCell count in knockouts^a^Cell count controls^a,\ b^Fold decrease in knockout*P*-value^c^*Vamp8*^−/−^Healthy7 days539±444±131.10.1761*Vamp8*^−/−^Small and sick8 to 12 days726±14261±1310.00.0017*Vamp8*^−/−^Small and healthy8 to 12 days4140±32265±241.90.0209*Vamp8*^−/−^Healthy1 to 1.5 months4170±14241±621.40.1489^a^×10^6b^*Vamp8*^+/−^ littermates were used as controls for *Vamp8*^−/−^ mice. The same number of control and knockout mice was used to determine thymocyte numbers^c^*P*-values were calculated by using the U test

The T cell receptor (TCR) is a key molecule, which must be expressed by DP thymocytes to have a chance for successful positive selection and by CD4 SP and CD8 SP cells for proper T cell function. Thymocytes with a TCR that cannot interact with self-MHC molecules die by neglect (Kisielow et al. [@CR16]). The most prominent reduction of the DP population prompted us to study the expression of the TCRαβ in the *Vamp8*^−/−^ mice. A flow cytometric analysis showed an increase in the percentage of TCR^high^ cells in small and sick *Vamp8*^−/−^ mice (Fig. [5](#Fig5){ref-type="fig"}d). This can been explained by the massive increase in the proportion of CD4^+^ and CD8^+^ SP cells in the thymi of these mice. The TCR expression level on the TCR^low^ and TCR^high^ cell populations was not markedly different between the genotypes. Similarly, the proportion of CD3^+^ cells was increased in thymi of *Vamp8*^−/−^ mice (data not shown).

CD4^−^CD8^−^ DN thymocytes subsets were disturbed in small and sick *Vamp8*^−/−^ mice {#Sec18}
-------------------------------------------------------------------------------------

Since the absolute numbers of DN thymocytes were also reduced, a block in their development might have been responsible for the prominent reduction of DP thymocytes in the small and sick *Vamp8*^−/−^ mice. Therefore, we performed an analysis of the DN subsets. The DN thymocytes are subdivided into four developmental stages depending on the sequential expression of surface molecules CD44 and CD25: DN1 (CD44^+^CD25^−^), DN2 (CD44^+^CD25^+^), DN3 (CD44^−^CD25^+^), and DN4 (CD44^−^CD25^−^; Godfrey et al. [@CR13]). In order to confine the analysis to the CD4^−^CD8^−^ T lymphocyte progenitor cells, we gated on the lymphocyte population in forward/sideward scatter plots and on cells that were negative for T cell (CD4, CD8, and CD3), B cell (B220), NK cell (NK1.1, and DX5), erythrocyte (TER-119), and granulocyte (Ly-6G) markers. Although we could detect all DN subpopulations (DN1--DN4) in the thymus from small and sick *Vamp8*^−/−^ mice, the percentage of these subsets was different from the controls (Fig. [6](#Fig6){ref-type="fig"}). The percentage of DN1 cells (CD44^+^CD25^−^, Fig. [6](#Fig6){ref-type="fig"}a) increased significantly (on an average six-fold), whereas the DN2 (CD44^+^CD25^+^, Fig. [6](#Fig6){ref-type="fig"}b) and DN3 (CD44^−^CD25^+^, Fig. [6](#Fig6){ref-type="fig"}c) cells were significantly (three-fold and 2.5-fold) reduced, respectively (*P* \< 0.05, U test, corrected for multiple testing). The DN4 (CD44^−^CD25^−^, Fig. [6](#Fig6){ref-type="fig"}d) population showed a tendency to increase (on average two-folds). Thus, the subpopulations within the DN compartment were also disturbed in small and sick *Vamp8*^−/−^ mice. The transition from DN1 to DN2 appeared to be most severely affected. In contrast, the small and healthy *Vamp8*^−/−^ and adult *Vamp8*^−/−^ mice showed no disturbance in the DN subpopulations (data not shown). Fig. 6VAMP8 deficiency led to a disturbance of DN thymocytes. A flow cytometric analysis of the DN precursor subsets in thymus of small and sick *Vamp8*^−/−^ mice was performed. Lymphocytes were gated according to their light scattering characteristics, and the lineage marker negative cells were gated in a second step. The DN cells were further separated into DN1 to DN4 subsets depending upon the intensity of staining for CD44 and CD25 markers. A distribution plot shows a summary of six independent experiments (age: 10--12 days) comparing the DN1 (**a**), DN2, (**b**), DN3 (**c**), and DN4 (**d**) subsets of small and sick *Vamp8*^−/−^ mice and *Vamp8*^+/−^ littermates

Proliferation of thymocytes in small and sick and in small and healthy *Vamp8*^−/−^ mice was reduced {#Sec19}
----------------------------------------------------------------------------------------------------

Thymocytes undergo several cycles of vigorous proliferation at defined developmental stages. To determine the proportion of proliferating cells in the thymus, we performed flow cytometric cell cycle analyses of propidium-iodide-stained ethanol-fixed cells (Fig. [7](#Fig7){ref-type="fig"}a). The proportion of proliferating cells in the S and G2 phases in small and sick *Vamp8*^−/−^ mice was significantly reduced compared with that in heterozygous littermates (Fig. [7](#Fig7){ref-type="fig"}b). In addition, the percentage of apoptotic cells appearing in the subG1 region of DNA histograms was increased. Interestingly, a reduced proliferation of thymocytes was also observed in small and healthy *Vamp8*^−/−^ mice (*P* = 0.014, U test), but the proportion of apoptotic cells was not increased (Fig. [7](#Fig7){ref-type="fig"}c). In adult *Vamp8*^−/−^ mice, the percentage of proliferating cells was not altered compared with that in heterozygous controls (data not shown). Fig. 7Proportion of proliferating thymocytes was decreased in small and sick *Vamp8*^−/−^ mice. **a** DNA histograms of thymocytes of a small and sick *Vamp8*^−/−^ mouse and a *Vamp8*^+/−^ control mouse were obtained in a representative flow cytometric analysis. The percentage of proliferating thymocytes in the S and G2 phase is decreased in the *Vamp8*^−/−^ mouse. In contrast, the proportion of apoptotic cells in the subG1 area is increased. **b** Summary of the cell cycle analysis of thymocytes obtained from small and sick *Vamp8*^−/−^ mice and heterozygous littermates (*bars* percentage of thymocytes in cell cycle phases 1+SD; *n* = 4, age: 9--12 days, \**P* \< 0.05, U test). **c** Thymi from small and healthy *Vamp8*^−/−^ mice (*n* = 4, age: 9--12 days) show a reduced percentage of proliferating cells compared with heterozygous littermates (\**P* \< 0.05, U test)

Small and sick *Vamp8*^−/−^ mice showed an increased number of apoptotic cells in the thymus {#Sec20}
--------------------------------------------------------------------------------------------

Thymocytes are subjected to stringent check points during their development. Those cells that do not pass through these checkpoints successfully are subjected to apoptotic cell death. The results of the cell cycle analysis, the observed disruption in thymus morphology, and the developmental defect of the thymocytes prompted us to study the extent of cell death in the thymi of *Vamp8*^−/−^ mice in more detail. Thymi from small and sick *Vamp8*^−/−^ mice (Fig. [8](#Fig8){ref-type="fig"}a) contained increased numbers of apoptotic cells compared with controls as shown by TUNEL staining in representative tissue sections (Fig. [8](#Fig8){ref-type="fig"}b). By contrast, the normal low levels of apoptotic cells were detected in thymus sections of small and healthy *Vamp8*^−/−^ mice (Fig. [8](#Fig8){ref-type="fig"}c), despite the disorganization of cTEC and mTEC detectable in these mice (see Fig. [4](#Fig4){ref-type="fig"}a,b). *Ex vivo* double-staining of thymocytes from small and sick *Vamp8*^−/−^ mice with annexin V and propidium iodide revealed an average of 41% live cells compared with 85% in the *Vamp8*^+/−^ controls (P = 0.0209, U test, Fig. [8](#Fig8){ref-type="fig"}d). The increased proportion of dead thymocytes was found predominantly among the DP cells in *Vamp8*^−/−^ mice when annexin V was combined with CD4 and CD8 staining (Fig. [8](#Fig8){ref-type="fig"}e). On the other hand, the thymi of small and healthy *Vamp8*^−/−^ and healthy adult *Vamp8*^−/−^ mice did not contain increased numbers of dead cells (Fig. [8](#Fig8){ref-type="fig"}d). Fig. 8VAMP8 deficiency led to increased rates of apoptotic thymocytes. **a**--**c** TUNEL staining of apoptotic cells in thymus sections revealed a high number of apoptotic cells in a small and sick *Vamp8*^−/−^ mouse (12 days old, **a**) compared with a heterozygous mouse (8 days old, **b**). **c** A small and healthy *Vamp8*^−/−^ littermate did not display increased apoptosis. *Bars* 20 µm. **d** Thymocytes of *Vamp8*^−/−^ mice and heterozygous littermates were stained with annexin V and propidium iodide. Summary of the proportion of annexin-V- and propidium-iodide-negative viable cells among thymocytes from small and sick (*n* = 4), small and healthy (*n* = 3), and adult (*n* = 6) *Vamp8*^−/−^ mice and their heterozygous littermates is shown (*bars* percentage of viable thymocytes ±SD). The small and sick *Vamp8*^−/−^ mice had significantly fewer viable thymocytes than their heterozygous littermates (*n* = 4, \**P* = 0.02, U test). **e** In a flow cytometric analysis, the percentage of annexin-V-positive apoptotic thymocytes was determined among the four major subpopulations defined by CD4 and CD8 markers (*bars* percentage of apoptotic thymocytes 1+SD as determined in small and healthy *Vamp8*^−/−^ mice and their heterozygous littermates; *n* = 3)

Isolated thymocytes from small and healthy *Vamp8*^−/−^ mice were more susceptible to apoptosis induced in vitro {#Sec21}
----------------------------------------------------------------------------------------------------------------

We reasoned that the reduced number of thymocytes in *Vamp8*^−/−^ mice might be attributable to an increased sensitivity of the cells toward apoptosis. Therefore, we studied the susceptibility of thymocytes from small and sick, from small and healthy, and from healthy adult *Vamp8*^−/−^ mice to several apoptotic stimuli. First, cell death was induced in isolated thymocytes with 0.1 µM dexamethasone. Ethanol-fixed cells were incubated with propidium iodide to determine DNA content. The number of cells appearing in the subG1 region of the DNA histograms was determined. Alternatively, the cells were stained with annexin V and propidium iodide. The number of viable cells was evaluated at various time points after treatment. More apoptosis was induced in thymocytes of small and healthy *Vamp8*^−/−^ mice at 3 h and 6 h after exposure to dexamethasone compared with *Vamp8*^+/−^ controls, as determined in DNA histograms (Fig. [9](#Fig9){ref-type="fig"}a) and by annexin V and propidium iodide staining (data not shown). This indicated that the isolated thymocytes from the small and healthy mice were more sensitive to cell death upon dexamethasone treatment. The thymocytes from small and sick *Vamp8*^−/−^ mice contained much fewer viable cells (on average 40%), even before dexamethasone treatment, and little additional apoptosis could be induced in these cells (data not shown). In adult *Vamp8*^−/−^ thymocytes, the rate of apoptosis induced by dexamethasone was not increased compared with *Vamp8*^+/−^ thymocytes (data not shown). Next, cell death was induced in isolated thymocytes from small and healthy *Vamp8*^−/−^ mice by stimulation with anti-CD3 and anti-CD28 antibodies. The percentage of cells in which apoptosis was induced was calculated by subtracting the percentage of viable cells in treated samples from that in untreated samples at each time point. The thymocytes from small and healthy *Vamp8*^−/−^ mice had a two-fold increased susceptibility to apoptosis when measured after 24 h (average 42% apoptosis induction) compared with the controls (average 21% apoptosis induction, Fig. [9](#Fig9){ref-type="fig"}b). Furthermore, thymocytes from small and healthy *Vamp8*^−/−^ mice showed an increased induction of apoptosis at 6 h after treatment with an apoptosis-inducing anti-FAS antibody compared with thymocytes from *Vamp8*^+/−^ littermates (Fig. [9](#Fig9){ref-type="fig"}c). These results indicated that the thymocytes from small and healthy *Vamp8*^−/−^ mice were more susceptible to apoptotic stimuli than those from their heterozygous littermates. Thus, an increased sensitivity to apoptosis could have contributed to the observed decrease in the total thymus cellularity observed in these mice. Fig. 9Isolated thymocytes of small and healthy *Vamp8*^−/−^ mice were more susceptible to apoptosis induced in vitro. **a** Isolated thymocytes from small and healthy *Vamp8*^−/−^ mice and heterozygous littermates were cultured in vitro in the absence (*co*) or presence of 0.1 µM dexamethasone (*Dex*) for 3 h and 6 h (*hr* hours). The proportion of apoptotic cells was determined by flow cytometry for DNA content after propidium iodide staining. A summary of the percentage of apoptosis in thymocytes from small and healthy *Vamp8*^−/−^ mice and heterozygous littermates is shown (*n* = 4, age: 8--13 days, \**P* \< 0.05, U test). The data points indicate the percentage of subG1 thymocytes 1+SD. **b** Thymocytes from small and healthy *Vamp8*^−/−^ mice and heterozygous littermates were treated with 10 µg/ml anti-CD3 and anti-CD28 antibodies for various times and stained with annexin V and propidium iodide. The viable cells were quantified by flow cytometry. The induction of apoptosis was calculated as the difference between the live cells in the untreated and treated samples at each time point. A summary of the induction of apoptosis is shown (*n* = 4, age: 8 days, \**P* \< 0.05, U test; *bars* percentage of thymocytes in which apoptosis was induced ±SD). **c** Thymocytes of small and healthy *Vamp8*^−/−^ mice and heterozygous littermates were treated with 1 µg of an agonistic anti-FAS antibody (clone Jo2, BD Pharmingen). A summary of the induction of apoptosis is shown (*n* = 4, age: 8 days, \**P* \< 0.05, U test; *bars* percentage of thymocytes in which apoptosis was induced ±SD)

Hematopoetic stem cells from small and sick *Vamp8*^−/−^ mice are not defective and give rise to T lymphocytes in *Rag2*^−/−^*γc*^−/−^ mice {#Sec22}
-------------------------------------------------------------------------------------------------------------------------------------------

The number of thymocytes in small and healthy *Vamp8*^−/−^ mice was found to be reduced, their proliferation was impaired, and their sensitivity to apoptosis was augmented in vitro despite a still normal distribution of thymocytes subsets and a normal rate of apoptotic thymocytes in vivo. Importantly, the organization of epithelial cells was also found to be disturbed even in the small and healthy *Vamp8*^−/−^ mice. Therefore, whether the VAMP8 deficiency in the stroma impaired T cell development or the VAMP8 deficiency in the thymocytes disturbed the organization of the stroma was unclear. To address this question, we transplanted bone marrow derived from five small and sick *Vamp8*^−/−^ and five healthy *Vamp8*^+/−^ littermates into *Rag2*^−/−^*γc*^−/−^ mice, which lack T and B lymphocytes (Fig. [10](#Fig10){ref-type="fig"}a,d,g) and natural killer cells but contain thymus stromal cells (Cao et al. [@CR6]). Bone marrow cells (1×10^6^) were intravenously injected into *Rag2*^−/−^*γc*^−/−^ mice that had been previously irradiated in order to open stem cell niches efficiently in the host bone marrow. The development of T and B lymphocytes was followed by analysis of the blood from the transplanted mice over a period of up to 23 weeks. After 4 weeks, the transplanted bone marrow gave rise to CD19 and B220-positive B lymphocytes in all mice (Fig. [10](#Fig10){ref-type="fig"}h,i, with data after 7 weeks). After 6--7 weeks, CD4^+^CD3^+^ (Fig. [10](#Fig10){ref-type="fig"}b,c) and CD8^+^CD3^+^ T lymphocytes (Fig. [10](#Fig10){ref-type="fig"}e,f) were found in the blood of all transplanted mice. After 14, 16, and 23 weeks, pairs of animals transplanted with bone marrow from small and sick *Vamp8*^−/−^ or healthy *Vamp8*^+/−^ littermates were sacrificed. In the thymi, between 60% and 79% CD4^+^CD8^+^ DP lymphocytes were found indicating an efficient repopulation by progenitor cells from small and sick *Vamp8*^−/−^ mice similar to that from *Vamp8*^+/−^ littermates. The spleens of these animals contained between 10% and 24% CD3^+^CD8^+^ cytotoxic T lymphocytes and between 17% and 24% CD3^+^CD4^+^ T helper lymphocytes. In addition, the number of thymocytes and splenocytes was in a similar range in mice receiving bone marrow from *Vamp8*^−/−^ mice or from *Vamp8*^+/−^ littermates (data not shown). Thus, the *Vamp8*^−/−^ lymphocyte progenitors are capable of differentiating into mature T lymphocytes, when introduced into an environment that is not VAMP8-deficient. This result suggests that the thymic environment is primarily affected by the VAMP8 deficiency. Fig. 10Bone marrow of small and sick *Vamp8*^−/−^ mice was able to repopulate *Rag2*^−/−^*γc*^−/−^ mice with peripheral T lymphocytes. Bone marrow cells (1×10^6^) from 10-day-old small and sick *Vamp8*^−/−^ mice (**b**, **e**, **h**) or *Vamp8*^+/−^ littermates (**c**, **f**, **h**) were injected intravenously into irradiated *Rag2*^−/−^*γc*^−/−^ mice. Control *Rag2*^−/−^*γc*^−/−^ mice were not transplanted (**a**, **d**, **g**). At 7 weeks after transplantation, blood samples were obtained from the recipients and analyzed for the presence of B and T lymphocytes by flow cytometry with antibodies against CD4 and CD3 (**a--c**) or CD8 and CD3 (**d--f**) for the T lymphocytes and against B220 and CD19 for the B lymphocytes (**g--i**). The progenitor cells from small and sick *Vamp8*^−/−^ mice gave rise to B220^+^CD19^+^ B-lymphocytes (**h**) and CD8^+^CD3^+^ (**e**) and CD4^+^CD3^+^ (**b**) T lymphocytes similarly to progenitor cells from the *Vamp8*^+/−^ bone marrow (**i**, **f**, **c**)

Discussion {#Sec23}
==========

In the current study, we demonstrate that the SNARE protein VAMP8 is expressed in the thymus, and that its lack leads to an alteration of thymus cytoarchitecture and subsequently T cell development. This phenotype can be mild and transient but also severe and associated with early postnatal mortality; 36% of the *Vamp8*^−/−^ mice died before reaching the age of 1 month.

The most severely affected *Vamp8*^−/−^ mice showed a characteristic developmental pattern, since they lost weight for 2--3 consecutive days before they eventually died. The VAMP8-deficient mice analyzed here were obtained by a gene trap strategy. A similar rate of early mortality (38%) was observed in an independent *Vamp8* knockout line in which exon 2 was removed (Wang et al. [@CR35]). In this previous study, VAMP8 was described to regulate the exocytosis of zymogen granules from pancreatic acinar cells (Wang et al. [@CR35]). The VAMP8-deficient mice analyzed in the present study showed similar morphological alterations in the pancreas as reported by Wang et al. ([@CR35]). These data indicate that the gene trap mice used in this study display similar phenotypes as the knockout mice. However, alterations of thymus morphology and T cell development attributable to VAMP8 deficiency have not previously been described.

The most prominent thymic alterations were observed in *Vamp8*^−/−^ mice that had previously lost weight for 2--3 days, i.e., the small and sick mice. The size of the thymus and the number of thymocytes were significantly reduced in these mice. Importantly, the numbers of all major subpopulations of thymocytes decreased. Thus, both DN to DP and DP to mature SP transitions might be compromised in *Vamp8*^−/−^ mice. Since the DP cells were the most severely affected, the proportion of these cells was also dramatically reduced in contrast to the other populations. The size of the DP population is decided by a balance between the input from proliferating DN cells and the survival of DP cells dependent on positive selection. The finding of a major loss of DP thymocytes might argue for an impairment of positive selection of TCR-expressing cells that are able to recognize self-MHC molecules with their antigen receptor (Starr et al. [@CR29]). However, the small and sick *Vamp8*^−/−^ mice expressed TCR, and the surface level on the TCR^low^ and TCR^high^ cell populations was not altered. The prominent shift toward TCR^high^ cells that was observed in *Vamp8*^−/−^ mice reflects the increased proportion of SP thymocytes in the affected mice.

The number of DN thymocytes was also reduced in the VAMP8-deficient mice. Mainly the CD25-positive DN2 and DN3 cells decreased among the DN thymocytes. At the DN3 stage, the thymocytes have to express a successfully rearranged TCRβ chain together with the invariant pre-TCRα chain, otherwise they undergo apoptosis (Starr et al. [@CR29]; Falk et al. [@CR10]). The reduction of DN thymocytes might be caused by either a diminished proliferation or an increased rate of apoptosis.

The affected small and sick *Vamp8*^−/−^ mice showed both a reduced proportion of proliferating cells and an increase in apoptotic cells. In flow cytometric analyses of annexin-V- and propidium-iodide-stained thymocytes, only about 40% of the cells from small and sick *Vamp8*^−/−^ mice turned out to be alive. Most of the cells were positive for both annexin V and propidium iodide indicating a rapid progression of apoptosis.

As the affected small and sick *Vamp8*^−/−^ mice undergo severe stress, this makes it difficult to distinguish primary effects caused by VAMP8 deficiency from secondary effects occurring during the progression to death. Therefore, we next focused our analysis on the small and healthy animals. These mice had stopped gaining weight or lost some weight for 1 day but were otherwise normal and active. At this stage, the mice did not show any disturbance of thymocyte subsets, and the number of apoptotic thymocytes was not increased. However, a reduced proportion of proliferating cells in the thymus and a decreased number of thymocytes was detectable, even at this stage. Isolated thymocytes from these mice turned out to be more susceptible to apoptotic stimuli delivered in vitro. The rate of cell death was increased in response to glucocorticoids, to FAS receptor, and to CD8/CD28-mediated signaling suggesting that different apoptotic pathways might be involved (Screpanti et al. [@CR28]; Strasser and Bouillet [@CR31]; Herold et al. [@CR14]). Since the external apoptotic stimuli were delivered in the absence of the thymic stroma, the increased sensitivity of thymocytes to apoptosis might be a cell autonomous feature of VAMP8-deficient thymocytes. The epithelial phenotype of the mice might also depend on an intrinsic defect of the thymocytes. Thymocytes and stromal cells are known to cross-talk, so that their development is interdependent (van Ewijk et al. [@CR9]; Rodewald [@CR26]),

On the other hand, not only the small and sick, but also the small and healthy *Vamp8*^−/−^ mice demonstrated a disturbed histological architecture, as seen in HE-stained tissue sections, but more specifically when the distribution of cTEC and mTEC was analyzed by keratin 5 and keratin 8 staining. Thus, the increased sensitivity of thymocytes to apoptosis in these mice could alternatively be caused by inappropriate conditioning by the VAMP8-deficient stroma as has been reported, for example, in mice with a STAT3 deficiency in the thymic epithelia only (Sano et al. [@CR27]).

To address this question, bone marrow transplantations were performed. Bone marrow cells derived from small and sick *Vamp8*^−/−^ mice with a clear phenotype and severe thymic alterations were readily able to repopulate *Rag2*^−/−^*γc*^−/−^ mice and gave rise to normal peripheral T lymphocytes. Thus, the development of the thymic phenotype appears to depend on the environment. The disorganized VAMP8-deficient stromal cells appear to be impaired in their ability to support T cell development. Therefore, the VAMP8 deficiency appears to disturb the organization of the thymic epithelium thereby reducing the proliferation of thymocytes and increasing their sensitivity to apoptotic stimuli. During the progression of the phenotype, increasing numbers of apoptotic thymocytes were observed in situ and *ex vivo*, and the DP developmental stage of the thymocytes was most severely reduced. The molecular pathway that is affected in the thymus of the *Vamp8*^−/−^ mice leading to a disturbed organization of the thymic epithelium remains unknown. Given the fundamental role of SNARE proteins in the transport of vesicles and cargo, numerous cellular pathways in the thymic stroma might be affected by VAMP8 deficiency.

How can the incomplete penetrance in the phenotype of the *Vamp8*^−/−^ mice be explained? Since the mice were maintained on a mixed genetic background, modifier genes, which differ in the C57BL/6 and 129SvJ strains, might influence the phenotype. Importantly, a similar reduced penetrance with respect to early mortality has been observed in a completely independent *Vamp8* knockout model (Wang et al. [@CR35]). We also have no indication that external factors are responsible for the variation, since we have always analyzed littermates. We did not observe any variations that could depend, for example, on the fitness of the individual animals to compete for feeding. The affected mice were not more frequent in large litters in which feeding might be more limited for weaker animals compared with small litters. Furthermore, heterozygous females were used for breading to exclude possible secondary effects attributable to the quality of nursing given by the VAMP8-deficient mothers. *Vamp8*^−/−^ mice might undergo a phase of reduced proliferation of thymocytes and increased susceptibility to apoptosis between days 8 and 12. This phase might not be critical without additional effects aggravating the thymic phenotype and leading to death. Thus, a stochastic phenomenon might influence whether an individual animal is affected so severely by the general effects of VAMP8 deficiency that recovery and survival are not possible.

SNARE proteins are known to mediate important functions in the immune system, e.g., during phagocytosis, secretion of cytokines, and degranulation of immune cells (Stow et al. [@CR30]). The family member VAMP8 appears to have a unique function in the thymus for the organization of the thymic epithelial cells and subsequently for the proliferation and apoptosis of developing T lymphocytes. VAMP8 is the first SNARE protein shown to have such a specific function in the thymus and during T cell development. The molecular pathways in which VAMP8 is involved within thymocytes remain to be elucidated. Knowledge of these pathways is needed if we are to understand how VAMP8 deficiency affects the organization of the microenvironment in the thymus.
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